1 Dear editor, Interleukin (IL)-6 has been suggested as one critical mediator in acute respiratory distress syndrome (ARDS) due to severe COVID-19. 1 Given that antiviral agents with a confirmed therapeutic effect for COVID-19 remains lacking, 2 